ABSTRACT
Background Hearing difficulty (HD) is one of the major health burdens in older adults. While aging-related changes in the peripheral auditory system play an important role, genetic variation associated with brain structure and function could also be involved in HD predisposition.
Methods We analyzed a large-scale HD genome-wide association study (GWAS; Ntotal = 501,825, 56% females) and GWAS data related to 3,935 brain imaging-derived phenotypes (IDPs) assessed in up to 33,224 individuals (52% females) using multiple magnetic resonance imaging (MRI) modalities. To investigate HD pleiotropy with brain structure and function, we conducted genetic correlation, latent causal variable (LCV), Mendelian randomization (MR), and multivariable generalized linear regression analyses. Additionally, we performed local genetic correlation and multi-trait colocalization analyses to identify genomic regions and loci implicated in the pleiotropic mechanisms shared between HD and brain IDPs.
Results We observed a widespread genetic correlation of HD with 120 IDPs in females, 89 IDPs in males, and 171 IDPs in the sex-combined analysis. The LCV analyses showed that some of these genetic correlations could be due to cause-effect relationships. For seven correlations, the causal effects were also confirmed by the MR approach: vessel volume→HD in the sex-combined analysis; hippocampus volume→HD, cerebellum grey matter volume→HD, primary visual cortex volume→HD, and HD→rfMRI-ICA100 node 46 in females; global mean thickness→HD and HD→mean orientation dispersion index in superior corona radiata in males. The local genetic correlation analyses identified 13 pleiotropic regions between HD and these seven IDPs. We also observed a colocalization signal for the rs13026575 variant between HD, primary visual cortex volume, and SPTBN1 transcriptomic regulation in females.
Conclusion Brain structure and function may have a role in the sex differences in HD predisposition via possible cause-effect relationships and shared regulatory mechanisms.
Competing Interest Statement
GCC is an employee of OM1and receives royalties from UpToDate for being an author and Section Editor. APM reports grants for clinical trials from Genentech, Eli Lilly, and Janssen Pharmaceuticals outside the submitted work. CHvD reports consulting fees from Eisai, Roche, Ono, and Cerevel and grants for clinical trials from Biogen, Eli Lilly, Eisai, Janssen, Roche, Genentech, UCB, and Cerevel, outside the submitted work. RP is paid for his editorial work on the journal Complex Psychiatry and received a research grant outside the scope of this study from Alkermes. The remaining authors declare that they have no competing interests.
Funding Statement
This study is funded by the National Institute on Deafness and Other Communication Disorders (R21 DC018098). The authors also acknowledge support from the National Institute on Drug Abuse (R33 DA047527), the National Institute of Mental Health (RF1 MH132337), and One Mind. GAP acknowledges support from the National Institute on Aging (K99 AG078503), Alzheimers Association Research Fellowship (AARF-22-967171), and the Yale Franke Program in Science and Humanities. DK is funded by the Horizon 2020 Marie Sklodowska-Curie Individual Fellowship 101028810 from the European Commission.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used publicly available human data.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript.
ABBREVIATIONS
- dMRI
- Diffusion MRI
- eQTL
- Expression quantitative trait loci
- FDR
- False discovery rate
- gcp
- Genetic causality proportions
- HD
- Hearing difficulty
- HyPrColoc
- Hypothesis prioritization in multi-trait colocalization
- IDPs
- Imaging-derived phenotypes
- IVs
- Instrumental variables
- IVW
- Inverse variance weighting
- LAVA
- Local analysis of [co]variant association
- LCV
- Latent causal variable
- LD
- Linkage disequilibrium
- LDSC
- Linkage disequilibrium score regression
- MAF
- Minor allele frequency
- MRI
- Magnetic resonance imaging
- PPFC
- Posterior probability of full colocalization
- PR
- Regional association probability
- Psnp
- PPFC explained by the candidate causal variant
- rg
- Genetic correlations
- rfMRI
- Resting-state functional MRI
- SWI
- Susceptibility-weighted imaging
- tfMRI
- Task functional MRI
- YLDs
- Years lived with disability
